Report Morocco - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

Morocco - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Morocco: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in Morocco

The Moroccan prophylactic medicaments containing insulin market fell sharply to $X in 2022, which is down by -18% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Overall, consumption, however, recorded a noticeable increase. As a result, consumption reached the peak level of $X. From 2021 to 2022, the growth of the market remained at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from Morocco

In 2022, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were exported from Morocco; picking up by 229% on the previous year's figure. Overall, exports enjoyed a prominent expansion. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

In value terms, prophylactic medicaments containing insulin exports soared to $X in 2022. In general, exports enjoyed a strong expansion. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

Exports by Country

Mauritania (X tons) was the main destination for prophylactic medicaments containing insulin exports from Morocco, with a 61% share of total exports. Moreover, prophylactic medicaments containing insulin exports to Mauritania exceeded the volume sent to the second major destination, Senegal (X tons), threefold. Libya (X kg) ranked third in terms of total exports with a 5.4% share.

From 2012 to 2022, the average annual rate of growth in terms of volume to Mauritania amounted to +20.1%. Exports to the other major destinations recorded the following average annual rates of exports growth: Senegal (+7.6% per year) and Libya (+3.7% per year).

In value terms, Mauritania ($X) remains the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from Morocco, comprising 63% of total exports. The second position in the ranking was taken by Senegal ($X), with a 21% share of total exports. It was followed by France, with a 7.6% share.

From 2012 to 2022, the average annual growth rate of value to Mauritania stood at +14.2%. Exports to the other major destinations recorded the following average annual rates of exports growth: Senegal (+5.6% per year) and France (+2.3% per year).

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2022, shrinking by -30.1% against the previous year. In general, the export price continues to indicate a noticeable decline. The growth pace was the most rapid in 2018 when the average export price increased by 31%. The export price peaked at $X per ton in 2013; however, from 2014 to 2022, the export prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was France ($X per ton), while the average price for exports to Libya ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Cameroon (+9.6%), while the prices for the other major destinations experienced a decline.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into Morocco

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses imported into Morocco fell to X tons, waning by -8.8% compared with the year before. Over the period under review, imports, however, showed prominent growth. The most prominent rate of growth was recorded in 2020 when imports increased by 72%. As a result, imports attained the peak of X tons. From 2021 to 2022, the growth of imports remained at a somewhat lower figure.

In value terms, prophylactic medicaments containing insulin imports declined to $X in 2022. Overall, total imports indicated tangible growth from 2012 to 2022: its value increased at an average annual rate of +3.5% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports decreased by -18.7% against 2020 indices. The pace of growth was the most pronounced in 2020 with an increase of 52% against the previous year. As a result, imports attained the peak of $X. From 2021 to 2022, the growth of imports remained at a somewhat lower figure.

Imports by Country

Germany (X tons), France (X tons) and Italy (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to Morocco, with a combined 88% share of total imports. Denmark and Malaysia lagged somewhat behind, together comprising a further 12%.

From 2012 to 2022, the biggest increases were recorded for Malaysia (with a CAGR of +30,366.7%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, the largest prophylactic medicaments containing insulin suppliers to Morocco were Germany ($X), France ($X) and Denmark ($X), with a combined 84% share of total imports. Italy and Malaysia lagged somewhat behind, together comprising a further 16%.

Malaysia, with a CAGR of +21,113.4%, saw the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average prophylactic medicaments containing insulin import price amounted to $X per ton, which is down by -6.4% against the previous year. In general, the import price showed a perceptible slump. The most prominent rate of growth was recorded in 2021 when the average import price increased by 9.9% against the previous year. The import price peaked at $X per ton in 2012; however, from 2013 to 2022, import prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Denmark ($X per ton), while the price for Malaysia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Denmark (+2.0%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

The countries with the highest volumes of in 2021 were China, the United States and India, with a combined 52% share of global consumption.
The countries with the highest volumes of in 2021 were China, the United States and India, together accounting for 52% of global production.
In value terms, France constituted the largest supplier of prophylactic medicaments containing insulin to Morocco, comprising 58% of total imports. The second position in the ranking was occupied by Germany, with a 26% share of total imports.
In value terms, France remains the key foreign market for prophylactic medicaments containing insulin exports from Morocco, comprising 91% of total exports. The second position in the ranking was occupied by Chad, with a 9.1% share of total exports.
In 2021, the average prophylactic medicaments containing insulin export price amounted to $131,149 per ton, declining by -1.7% against the previous year.
In 2021, the average prophylactic medicaments containing insulin import price amounted to $99,618 per ton, increasing by 3.2% against the previous year.

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Morocco. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale

Country coverage:

  • Morocco

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Morocco
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023

Recommended reports

Free Data: Medicaments Containing Insulin But Not Antibiotics In Measured Doses - Morocco